Comparison of Two Different Regional Analgesia Techniques for Patients Undergoing Total Knee Arthroplasty
PIPACK
Analgesic Efficacy of IPACK Versus Selective Tibial Nerve Block in Patients Undergoing Total Knee Arthroplasty Under Spinal Anesthesia With an Adductor Canal Block: a Randomized Controlled Double-blinded Trial
1 other identifier
interventional
100
1 country
1
Brief Summary
The objective of this clinical trial is to compare two regional analgesia techniques in patients undergoing total knee arthroplasty: IPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) vs selective tibial nerve block. The main question is whether one of these peripheral blocks is more effective in reducing postoperative pain than the other. All patients will have a spinal block with an adductor canal block. One group will receive an IPACK block and the other group, a selective tibial nerve block. Postoperative pain scores and morphine consumption, among others, will be compared between groups.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 30, 2023
CompletedFirst Posted
Study publicly available on registry
December 22, 2023
CompletedStudy Start
First participant enrolled
February 8, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 12, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 18, 2025
CompletedFebruary 9, 2024
February 1, 2024
1.4 years
November 30, 2023
February 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total iv morphine consumption
consumption in mg
24 hours postoperatively
Secondary Outcomes (12)
Morphine consumption in the recovery room
From admission till discharge from the recovery room, up to 2 hours
PCA administered morphine consumption
at day 1, day 2 and day 3 postoperatively
rest and dynamic pain scores
at day 1, day 2 and day 3 postoperatively
Duration of peripheral nerve block
From execution of a peripheral nerve block till administration of a first dose of iv morphine, up to 48 hours
Incidence of postoperative nausea and vomiting
at day 1, day 2 and day 3 postoperatively
- +7 more secondary outcomes
Study Arms (2)
IPACK group
ACTIVE COMPARATORIPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) block
Tibial nerve group
EXPERIMENTALselective tibial nerve block
Interventions
The selective tibial nerve block will be performed on the popliteal crease following sterilization of the area. The probe will be placed in a transverse position at the popliteal crease to visualize the popliteal artery and the tibial nerve in short axis. A 21-gauge 50mm insulated facet tip needle (SonoPlex® STIM, Pajunk, Geisingen, DE) will be inserted in-plane with the ultrasound bean from a medial to lateral direction. Once the needle tip is adjacent to the tibial nerve, 5 ml of ropivacaine 0.75% will be injected to achieve an adequate spread of local anesthetics around the nerve.
The IPACK (Infiltration of local anesthetic between the Popliteal Artery and Capsule of the Knee) will be performed on the popliteal crease following sterilization of the area. The probe will be placed in a transverse position proximal to the popliteal crease to visualize the popliteal artery in short axis. A 21-gauge 100 mm insulated facet tip needle (SonoPlex® STIM, Pajunk, Geisingen, DE) will be inserted in-plane with the ultrasound beam, in a lateral to medial direction, between the popliteal artery and the posterior capsule, where nineteen mL of ropivacaine 0.2% will be injected under ultrasound guidance. The distribution of local anesthetics will be observed above the posterior capsule.
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists classification I-III
- yo or older
- patients scheduled for total knee arthroplasty under central spinal anesthesia
- informed consent signed
You may not qualify if:
- Refusal or inability for informed consent
- Known allergies to ropivacaine, acetaminophen, ibuprofen, ketorolac, morphine, ondansetron or dexamethasone
- Secondary surgical revision
- Opioid treatment such as morphine, hydrocodone, hydromorphone, tramadol, methadone, fentanyl, buprenorphine or codeine
- Bleeding diathesis
- Neurological deficit
- Known renal insufficiency (eGFR \<45 ml/min)
- Known hepatic insufficiency (Child score B or C)
- Alcohol abuse
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Lausanne
Lausanne, Canton of Vaud, 1011, Switzerland
Related Publications (8)
Singelyn FJ, Deyaert M, Joris D, Pendeville E, Gouverneur JM. Effects of intravenous patient-controlled analgesia with morphine, continuous epidural analgesia, and continuous three-in-one block on postoperative pain and knee rehabilitation after unilateral total knee arthroplasty. Anesth Analg. 1998 Jul;87(1):88-92. doi: 10.1097/00000539-199807000-00019.
PMID: 9661552BACKGROUNDScott CE, Howie CR, MacDonald D, Biant LC. Predicting dissatisfaction following total knee replacement: a prospective study of 1217 patients. J Bone Joint Surg Br. 2010 Sep;92(9):1253-8. doi: 10.1302/0301-620X.92B9.24394.
PMID: 20798443BACKGROUNDWilliams DP, O'Brien S, Doran E, Price AJ, Beard DJ, Murray DW, Beverland DE. Early postoperative predictors of satisfaction following total knee arthroplasty. Knee. 2013 Dec;20(6):442-6. doi: 10.1016/j.knee.2013.05.011. Epub 2013 Jun 16.
PMID: 23777807BACKGROUNDBourne RB, Chesworth BM, Davis AM, Mahomed NN, Charron KD. Patient satisfaction after total knee arthroplasty: who is satisfied and who is not? Clin Orthop Relat Res. 2010 Jan;468(1):57-63. doi: 10.1007/s11999-009-1119-9.
PMID: 19844772BACKGROUNDvan der Wal M, Lang SA, Yip RW. Transsartorial approach for saphenous nerve block. Can J Anaesth. 1993 Jun;40(6):542-6. doi: 10.1007/BF03009739.
PMID: 8403121BACKGROUNDFischer HB, Simanski CJ, Sharp C, Bonnet F, Camu F, Neugebauer EA, Rawal N, Joshi GP, Schug SA, Kehlet H; PROSPECT Working Group. A procedure-specific systematic review and consensus recommendations for postoperative analgesia following total knee arthroplasty. Anaesthesia. 2008 Oct;63(10):1105-23. doi: 10.1111/j.1365-2044.2008.05565.x. Epub 2008 Jul 10.
PMID: 18627367BACKGROUNDSilverman ER, Vydyanathan A, Gritsenko K, Shaparin N, Singh N, Downie SA, Kosharskyy B. The Anatomic Relationship of the Tibial Nerve to the Common Peroneal Nerve in the Popliteal Fossa: Implications for Selective Tibial Nerve Block in Total Knee Arthroplasty. Pain Res Manag. 2017;2017:7250181. doi: 10.1155/2017/7250181. Epub 2017 Feb 2.
PMID: 28260964BACKGROUNDPaulou F, Wegrzyn J, Rossel JB, Gonvers E, Antoniadis A, Kagi M, Wolmarans MR, Lambert J, Albrecht E. Analgesic efficacy of selective tibial nerve block versus partial local infiltration analgesia for posterior pain after total knee arthroplasty: a randomized, controlled, triple-blinded trial. Anaesth Crit Care Pain Med. 2023 Aug;42(4):101223. doi: 10.1016/j.accpm.2023.101223. Epub 2023 Apr 6.
PMID: 37030393BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- quadruple
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Med. Eric Albrecht
Study Record Dates
First Submitted
November 30, 2023
First Posted
December 22, 2023
Study Start
February 8, 2024
Primary Completion
July 12, 2025
Study Completion
July 18, 2025
Last Updated
February 9, 2024
Record last verified: 2024-02